Sernova Biotherapeutics Inc. is a clinical-stage biotechnology company, which engages in advancing regenerative medicine in the treatment of chronic diseases. It focuses on its proprietary Cell Pouch, a bio-hybrid organ system which is designed to enhance the delivery of cell therapy to better replicate natural body functions. The company was founded on August 19, 1998 and is headquartered in London, Canada.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
17
Frequently Asked Questions
What is Market Cap of Sernova Biotherapeutics Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Sernova Biotherapeutics Inc. market cap is $43.56M.
What is the 52-week high for Sernova Biotherapeutics Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Sernova Biotherapeutics Inc. 52 week high is $0.2432 as of September 09, 2025.
What is the 52-week low for Sernova Biotherapeutics Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Sernova Biotherapeutics Inc. 52 week low is $0.104 as of September 09, 2025.
What is Sernova Biotherapeutics Inc. stock price today?
Sernova Biotherapeutics Inc. stock price today is $0.1405.
What was Sernova Biotherapeutics Inc. stock price yesterday?
Sernova Biotherapeutics Inc. stock price yesterday was $0.1326.
What is the PE ratio of Sernova Biotherapeutics Inc.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Sernova Biotherapeutics Inc.’s P/E ratio is -2.67.
What is the Price-to-Book ratio of Sernova Biotherapeutics Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Sernova Biotherapeutics Inc. P/B ratio is -2.9124.
What is the 50-day moving average of Sernova Biotherapeutics Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Sernova Biotherapeutics Inc. 50-day moving average is $0.1312.
How many employess does Sernova Biotherapeutics Inc. has?